Format

Send to

Choose Destination
Vaccine. 2017 Dec 4;35(48 Pt A):6501-6505. doi: 10.1016/j.vaccine.2017.01.045.

Neonatal encephalopathy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data.

Author information

1
Children's Hospital of Eastern Ontario, Canada. Electronic address: contact@brightoncollaboration.org.
2
Baylor College of Medicine, United States.
3
Medway Maritime Hospital, Gillingham, Kent, United Kingdom.
4
Rainbow Babies and Children's Hospital in Cleveland, United States.
5
St. Georges Vaccine Institute, Institute of Infection & Immunity, St. Georges, University of London, London, UK.
6
Medical Research Unit, Gambia.
7
Henry M. Jackson Foundation, Kelly Government Solutions (KGS), Contractor to DAIDS/NIAID/NIH, Rockville, United States.
8
Therapeutic Area Lead, Vaccines, Safety Risk Management, Australian QPPVCSL Limited Melbourne, Australia.
9
National Institute of Public Health, Ljubljana, Slovenia.
10
Sanofi Pasteur, United States.
11
University of Calgary, Section of Neonatology, Department of Pediatrics, Foothills Medical Centre, Canada.
12
Global Healthcare Consulting, Delhi, India; Erasmus University Medical Center, Rotterdam, The Netherlands.

KEYWORDS:

Adverse event; Case definition; Guidelines; Immunisation; Neonatal encephalopathy

PMID:
29150055
PMCID:
PMC5710979
DOI:
10.1016/j.vaccine.2017.01.045
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center